Update to Communicable Disease Control Manual, Chapter 2: Immunization, Part 4 – Biological Products & Appendix E – Management of Biologicals

Updated on: August 5, 2022

CDC

BCCDC Guidance Manual updated for COVID-19 Vaccine Eligibility: A new product page has been developed for the Comirnaty® (Pfizer-BioNTech) Adult/Adolescent vaccine supplied with a gray vial cap and gray border around the vial. Content related to reported rates of myocarditis under Adverse Events has been updated (Pfizer-BioNTech), this and more. 

Click here to access the Immunization Manual page and supporting documents. 

COVID-19 Vaccine Eligibility

 

Information is considered to be true and correct at the date of publication, changes in circumstances after the time of publication may impact on the accuracy of the information.